BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 21760580)

  • 1. Genetics: finding risk factors.
    Eisenstein M
    Nature; 2011 Jul; 475(7355):S20-2. PubMed ID: 21760580
    [No Abstract]   [Full Text] [Related]  

  • 2. Integrated late onset Alzheimer's disease (LOAD) susceptibility genes: Cholesterol metabolism and trafficking perspectives.
    Dong HK; Gim JA; Yeo SH; Kim HS
    Gene; 2017 Jan; 597():10-16. PubMed ID: 27773727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of clusterin, complement receptor 1, and phosphatidylinositol binding clathrin assembly protein in Alzheimer disease risk and cerebrospinal fluid biomarker levels.
    Schjeide BM; Schnack C; Lambert JC; Lill CM; Kirchheiner J; Tumani H; Otto M; Tanzi RE; Lehrach H; Amouyel P; von Arnim CA; Bertram L
    Arch Gen Psychiatry; 2011 Feb; 68(2):207-13. PubMed ID: 21300948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Alzheimer's disease risk genes: exhaustive investigation is paramount.
    Sleegers K; Van Broeckhoven C
    Acta Neuropathol; 2019 Aug; 138(2):171-172. PubMed ID: 31300866
    [No Abstract]   [Full Text] [Related]  

  • 5. SORL1 genetic variants and Alzheimer disease risk: a literature review and meta-analysis of sequencing data.
    Campion D; Charbonnier C; Nicolas G
    Acta Neuropathol; 2019 Aug; 138(2):173-186. PubMed ID: 30911827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alzheimer's disease: The forgetting gene.
    Spinney L
    Nature; 2014 Jun; 510(7503):26-8. PubMed ID: 24899289
    [No Abstract]   [Full Text] [Related]  

  • 7. Alzheimer's disease beyond APOE.
    van Es MA; van den Berg LH
    Nat Genet; 2009 Oct; 41(10):1047-8. PubMed ID: 19786950
    [No Abstract]   [Full Text] [Related]  

  • 8. Genetic evidence for the involvement of lipid metabolism in Alzheimer's disease.
    Jones L; Harold D; Williams J
    Biochim Biophys Acta; 2010 Aug; 1801(8):754-61. PubMed ID: 20420935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single Nucleotide Polymorphisms in Alzheimer's Disease Risk Genes Are Associated with Intrinsic Connectivity in Middle Age.
    Blujus JK; Korthauer LE; Awe E; Frahmand M; Driscoll I
    J Alzheimers Dis; 2020; 78(1):309-320. PubMed ID: 32986668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanisms of the genetic risk factors in pathogenesis of Alzheimer disease.
    Kanatsu K; Tomita T
    Front Biosci (Landmark Ed); 2017 Jan; 22(1):180-192. PubMed ID: 27814610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular cholesterol homeostasis and Alzheimer's disease.
    Chang TY; Yamauchi Y; Hasan MT; Chang C
    J Lipid Res; 2017 Dec; 58(12):2239-2254. PubMed ID: 28298292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-nucleotide polymorphisms of GSK3B, GAB2 and SORL1 in late-onset Alzheimer's disease: interactions with the APOE genotype.
    Izzo G; Forlenza OV; Santos Bd; Bertolucci PH; Ojopi EB; Gattaz WF; Kerr DS
    Clinics (Sao Paulo); 2013; 68(2):277-80. PubMed ID: 23525328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alzheimer disease: New light on an old CLU.
    Bertram L; Tanzi RE
    Nat Rev Neurol; 2010 Jan; 6(1):11-3. PubMed ID: 20057494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of ABCA7 in Human Health and in Alzheimer's Disease.
    Dib S; Pahnke J; Gosselet F
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alzheimer risk associated with a copy number variation in the complement receptor 1 increasing C3b/C4b binding sites.
    Brouwers N; Van Cauwenberghe C; Engelborghs S; Lambert JC; Bettens K; Le Bastard N; Pasquier F; Montoya AG; Peeters K; Mattheijssens M; Vandenberghe R; Deyn PP; Cruts M; Amouyel P; Sleegers K; Van Broeckhoven C
    Mol Psychiatry; 2012 Feb; 17(2):223-33. PubMed ID: 21403675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution to Alzheimer's disease risk of rare variants in TREM2, SORL1, and ABCA7 in 1779 cases and 1273 controls.
    Bellenguez C; Charbonnier C; Grenier-Boley B; Quenez O; Le Guennec K; Nicolas G; Chauhan G; Wallon D; Rousseau S; Richard AC; Boland A; Bourque G; Munter HM; Olaso R; Meyer V; Rollin-Sillaire A; Pasquier F; Letenneur L; Redon R; Dartigues JF; Tzourio C; Frebourg T; Lathrop M; Deleuze JF; Hannequin D; Genin E; Amouyel P; Debette S; Lambert JC; Campion D;
    Neurobiol Aging; 2017 Nov; 59():220.e1-220.e9. PubMed ID: 28789839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Alzheimer disease: experimental approaches to genetic and environmental risk factors].
    Iwatsubo T; Hashimoto T; Wakabayashi T; Tomita T; Morohashi Y
    Rinsho Shinkeigaku; 2013; 53(11):956. PubMed ID: 24291845
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of Alzheimer's disease risk genes on trajectories of cognitive function in the Cardiovascular Health Study.
    Sweet RA; Seltman H; Emanuel JE; Lopez OL; Becker JT; Bis JC; Weamer EA; DeMichele-Sweet MA; Kuller LH
    Am J Psychiatry; 2012 Sep; 169(9):954-62. PubMed ID: 22952074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible association between SORL1 and Alzheimer disease? Reanalysing the data of Shibata et al.
    Lee JH; Shibata N; Cheng R; Mayeux R
    Dement Geriatr Cogn Disord; 2008; 26(5):482. PubMed ID: 18984959
    [No Abstract]   [Full Text] [Related]  

  • 20. Meta-analysis of the Association between Alzheimer Disease and Variants in GAB2, PICALM, and SORL1.
    Wang Z; Lei H; Zheng M; Li Y; Cui Y; Hao F
    Mol Neurobiol; 2016 Nov; 53(9):6501-6510. PubMed ID: 26611835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.